JO
Rating #13
Johnson & Johnson
Portfolio value
Stocks
Performance
1 Year
+102.96%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Top10 stocks: 98.99% of the portfolio
Adds
New Buys
Sold Outs
Cuts
Company Name | Primary Industry | Avg. price paid | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 ![]() PTGX | Pharmaceutical Pres | $17.72 | 0.00% | 2.45M | $258.14M | 39.57% 1.03ppt | 3.85% | 19 Quarters | Q3 2021 | |
2 ![]() NBTX | Pharmaceutical Pres | $7.53 | 0.00% | 5.62M | $173.61M | 26.61% 3.19ppt | 11.76% | 11 Quarters | Q4 2023 | |
3 ![]() MGTX | Biological products | $9.43 | 0.00% | 6.64M | $57.51M | 8.82% -0.70ppt | 8.19% | 19 Quarters | Q4 2022 | |
4 ![]() RAPP | Pharmaceutical Pres | $25.44 | 0.00% | 1.78M | $55.84M | 8.56% -1.20ppt | 3.80% | 8 Quarters | Q3 2025 | |
5 ![]() CVRX | Surgical Instruments | $16.75 | 0.00% | 4.02M | $38.08M | 5.84% 0.69ppt | 15.35% | 19 Quarters | Q4 2025 | |
6 ![]() CTNM | Pharmaceutical Pres | $21.00 | 0.00% | 1.98M | $25.85M | 3.96% -0.11ppt | 7.14% | 8 Quarters | Q2 2024 | |
7 ![]() LEGN | Pharmaceutical Pres | $50.56 | 0.00% | 814.59K | $14.74M | 2.26% -0.93ppt | 0.44% | 19 Quarters | Q2 2023 | |
8 ![]() XNCR | Pharmaceutical Pres | $40.12 | 0.00% | 748.06K | $9.02M | 1.38% -0.68ppt | 1.01% | 18 Quarters | Q4 2021 | |
9 ![]() PRCT | Surgical Instruments | $38.15 | 0.00% | 357.94K | $8.95M | 1.37% -0.66ppt | 0.64% | 19 Quarters | Q4 2022 | |
10 ![]() FATE | Biological products | $59.27 | 0.00% | 3.38M | $4.05M | 0.62% 0.02ppt | 2.84% | 19 Quarters | Q3 2021 | |
11 ![]() NMRA | Biological products | $15.60 | 0.00% | 1.85M | $3.61M | 0.55% -0.04ppt | 1.13% | 11 Quarters | Q4 2023 | |
12 ![]() RLYB | Pharmaceutical Pres | $8.97 | New Buy +100.00% | 152.90K | $1.37M | 0.21% 0.21ppt | 2.69% | 1 Quarter | Q1 2026 | |
13 ![]() VOR | Biological products | $48.72 | 0.00% | 53.73K | $958.58K | 0.15% 0.02ppt | 0.54% | 3 Quarters | Q3 2025 | |
14 ![]() LAB | Lab Analytical Instruments | $2.70 | 0.00% | 311.97K | $286.79K | 0.04% -0.03ppt | 0.08% | 9 Quarters | Q1 2024 | |
15 ![]() NNOX | X-Ray Apparatus | $11.10 | Cut -47.40% | 83.55K | $189.67K | 0.03% -0.05ppt | 0.13% | 18 Quarters | Q1 2026 | |
16 ![]() ACET | Pharmaceutical Pres | $8.42 | 0.00% | 22.78K | $155.13K | 0.02% -0.01ppt | 0.33% | 2 Quarters | Q4 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers